PL1858496T3 - Poprzezskórny układ terapeutyczny do aplikowania środków przeciwbólowych - Google Patents
Poprzezskórny układ terapeutyczny do aplikowania środków przeciwbólowychInfo
- Publication number
- PL1858496T3 PL1858496T3 PL06724947T PL06724947T PL1858496T3 PL 1858496 T3 PL1858496 T3 PL 1858496T3 PL 06724947 T PL06724947 T PL 06724947T PL 06724947 T PL06724947 T PL 06724947T PL 1858496 T3 PL1858496 T3 PL 1858496T3
- Authority
- PL
- Poland
- Prior art keywords
- analgesics
- administration
- therapeutic system
- transdermal therapeutic
- transdermal
- Prior art date
Links
- 229940035676 analgesics Drugs 0.000 title 1
- 239000000730 antalgic agent Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005011517A DE102005011517A1 (de) | 2005-03-10 | 2005-03-10 | Transdermales therapeutisches System zur Verabreichung von Analgetika |
| PCT/EP2006/060484 WO2006094961A1 (de) | 2005-03-10 | 2006-03-06 | Transdermales therapeutisches system zur verabreichung von analgetika |
| EP06724947A EP1858496B1 (de) | 2005-03-10 | 2006-03-06 | Transdermales therapeutisches system zur verabreichung von analgetika |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1858496T3 true PL1858496T3 (pl) | 2009-01-30 |
Family
ID=36514546
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06724947T PL1858496T3 (pl) | 2005-03-10 | 2006-03-06 | Poprzezskórny układ terapeutyczny do aplikowania środków przeciwbólowych |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20070298091A1 (pl) |
| EP (1) | EP1858496B1 (pl) |
| AR (1) | AR054012A1 (pl) |
| AT (1) | ATE401870T1 (pl) |
| DE (2) | DE102005011517A1 (pl) |
| ES (1) | ES2311281T3 (pl) |
| PE (1) | PE20061244A1 (pl) |
| PL (1) | PL1858496T3 (pl) |
| WO (1) | WO2006094961A1 (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10146815B4 (de) | 2001-09-18 | 2005-05-04 | Ing. Erich Pfeiffer Gmbh | Spender für Medien |
| DE10356362A1 (de) | 2003-11-28 | 2005-06-23 | Grünenthal GmbH | Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie von Angststörungen |
| DE102006054733A1 (de) | 2006-11-21 | 2008-05-29 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit |
| US20100256197A1 (en) * | 2009-04-02 | 2010-10-07 | Silver Eagle Labs Nv, Llc | Nicotine Dissolving Film With Or Without Menthol |
| DE102011076653A1 (de) * | 2011-05-27 | 2012-11-29 | Acino Ag | Transdermales therapeutisches System enthaltend Buprenorphin und eine alpha-Hydroxysäure |
| US8515525B2 (en) | 2011-08-16 | 2013-08-20 | Women's Imaging Solutions Enterprises Llc | Skin adhesive agent for mammography procedures |
| PL2872126T3 (pl) * | 2012-07-16 | 2018-06-29 | Grünenthal GmbH | Plaster farmaceutyczny do przezskórnego podawania tapentadolu |
| CN104955516B (zh) | 2012-12-28 | 2019-01-22 | 帝国制药美国公司 | 延长丁丙诺啡经皮递送组合物及其使用方法 |
| US20180235903A1 (en) * | 2015-03-13 | 2018-08-23 | Amneal Pharmaceuticals Llc | Fentanyl Transdermal Delivery System |
| GB201513442D0 (en) * | 2015-07-30 | 2015-09-16 | Euro Celtique Sa | Transdermal patch |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3900610A (en) * | 1973-04-09 | 1975-08-19 | Monsanto Co | Process of making a pressure sensitive adhesive article |
| JPS6059207B2 (ja) * | 1981-03-13 | 1985-12-24 | 日東電工株式会社 | 複合製剤の製法 |
| DE3315245A1 (de) * | 1983-04-27 | 1984-10-31 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches produkt |
| DE3315272C2 (de) * | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches Produkt und Verfahren zu seiner Herstellung |
| ATE131384T1 (de) * | 1990-04-24 | 1995-12-15 | Teijin Ltd | Pflaster |
| US5429590A (en) * | 1992-12-01 | 1995-07-04 | Nitto Denko Corporation | Medical water-absorptive polymer and dressing for wound and medical bandage using the same |
| US6093419A (en) * | 1995-06-07 | 2000-07-25 | Lectec Corporation | Compliance verification method and device in compulsory drug administration |
| JP4659943B2 (ja) * | 2000-02-25 | 2011-03-30 | 帝三製薬株式会社 | 塩酸ブプレノルフィン含有貼付剤 |
| EP1323421A1 (en) * | 2001-12-20 | 2003-07-02 | Grünenthal GmbH | Use of buprenorphine for the manufacture of a transdermal delivery device for the treatment of urinary incontinence, especially urge incontinence |
-
2005
- 2005-03-10 DE DE102005011517A patent/DE102005011517A1/de not_active Withdrawn
-
2006
- 2006-03-06 PL PL06724947T patent/PL1858496T3/pl unknown
- 2006-03-06 AR ARP060100843A patent/AR054012A1/es not_active Application Discontinuation
- 2006-03-06 WO PCT/EP2006/060484 patent/WO2006094961A1/de not_active Ceased
- 2006-03-06 ES ES06724947T patent/ES2311281T3/es active Active
- 2006-03-06 PE PE2006000249A patent/PE20061244A1/es not_active Application Discontinuation
- 2006-03-06 AT AT06724947T patent/ATE401870T1/de active
- 2006-03-06 EP EP06724947A patent/EP1858496B1/de not_active Revoked
- 2006-03-06 DE DE502006001195T patent/DE502006001195D1/de active Active
-
2007
- 2007-09-07 US US11/851,645 patent/US20070298091A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2311281T3 (es) | 2009-02-01 |
| ATE401870T1 (de) | 2008-08-15 |
| EP1858496A1 (de) | 2007-11-28 |
| PE20061244A1 (es) | 2007-01-06 |
| WO2006094961A1 (de) | 2006-09-14 |
| DE502006001195D1 (de) | 2008-09-04 |
| US20070298091A1 (en) | 2007-12-27 |
| AR054012A1 (es) | 2007-05-30 |
| DE102005011517A1 (de) | 2006-09-21 |
| EP1858496B1 (de) | 2008-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2292219T3 (pl) | Transdermalny system terapeutyczny | |
| IL245290A0 (en) | A medical system for introducing the active substance buprenorphine through the skin | |
| GB0415112D0 (en) | Therapeutic device | |
| EP1877134A4 (en) | TRANSDERMAL SYSTEMS FOR IONOPHORESIS DELIVERY OF THERAPEUTIC AGENTS COMPRISING GRANISETRON | |
| EP1796676A4 (en) | TRANSDERMALE ADMINISTRATION OF PHYCOTOXINES | |
| ZA200809004B (en) | Autodestructive transdermal therapeutic system | |
| PL1858496T3 (pl) | Poprzezskórny układ terapeutyczny do aplikowania środków przeciwbólowych | |
| GB0419240D0 (en) | Therapeutic device | |
| IL281624B1 (en) | Ultrasound system for medical treatment | |
| GB0427138D0 (en) | Therapeutic compounds | |
| EP1900363A4 (en) | THERAPEUTIC AGENT AGAINST PAIN | |
| EP1757603A4 (en) | THERAPEUTIC AGENT FOR KERAATOCONJUNCTIVITIS AFFECTION | |
| GB0722015D0 (en) | Transdermal therapy | |
| GB0423767D0 (en) | Therapeutic compounds | |
| GB0417560D0 (en) | Therapeutic compounds | |
| HK1120435A (en) | Transdermal therapeutic system | |
| HK1123991A (en) | Transdermal therapeutic system comprising scopolamine | |
| GB0602168D0 (en) | Therapeutic preparations for the therapy of dermatoses | |
| GB0511259D0 (en) | Therapeutic utrasound system | |
| GB0411762D0 (en) | Therapeutic medical device | |
| GB0406498D0 (en) | Therapeutic device | |
| GB0622285D0 (en) | Transdermal therapy | |
| HU0501133D0 (en) | Therapeutic apparatus called home magnetotherapy system | |
| GB0408959D0 (en) | Therapeutic agent | |
| HK1125865A (en) | Therapeutic combination for painful medical conditions |